Your search returned 188 studies. (Get alerts for new studies):
- Screening Methods for Finding Ovarian Cancer
Conditions: Cervical Cancer - Endometrial Cancer - Fallopian Tube Cancer - Hereditary Breast and Ovarian Cancer Syndrome - Ovarian Cancer - Sarcoma - Uterine Fibroids - Vaginal Cancer - Vulvar Cancer
1 Location available
- Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallo
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
209 Locations available
- Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
Conditions: Brain and Central Nervous System Tumors - Extragonadal Germ Cell Tumor - Ovarian Cancer - Teratoma - Testicular Germ Cell Tumor
2 Locations available
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
Conditions: Breast Cancer - Colorectal Cancer - Gastric Cancer - Liver Cancer - Melanoma (Skin) - Metastatic Cancer - Ovarian Cancer - Pancreatic Cancer
1 Location available
- Carboplatin and Paclitaxel With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
245 Locations available
- Spectroscopy With Surface Coils and Decoupling
Conditions: Adrenal Cortical Cancer - Brain Cancer - Breast Cancer - CNS Cancer - Colon Cancer - HEENT Cancer - Hodgkin's Disease - Kaposi's Sarcoma - Liver Cancer - Lung Cancer - Non-Hodgkin's Lymphoma - Ovarian Cancer - Pancreatic Cancer - Prostate Cancer - Rectal
1 Location available
- Viral Therapy in Treating Patients With Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Did Not Respond to Platinu
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Trial of Autologous, Hapten-Modified Vaccine, OVAX, in Patients With Relapsed Stage III or IV Ovarian Cancer
Conditions: Adenocarcinoma of the Ovary
3 Locations available
- Standard Genetic Counseling With or Without a Decision Guide in Improving Communication Between Mothers Undergoing BRCA1/2 Testing and Their Minor-Age
Conditions: Breast Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2)
2 Locations available
- Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors
Conditions: Cancer - Non-Small Cell Lung Cancer - Endometrial Carcinoma - Ovarian Carcinoma
3 Locations available
- Dasatinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot be Removed by Surgery
Conditions: Breast Cancer - Gastrointestinal Stromal Tumor - Intraocular Melanoma - Kidney Cancer - Lung Cancer - Melanoma (Skin) - Ovarian Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer
Conditions: Breast Cancer
2 Locations available
- Vorinostat, Carboplatin and Gemcitabine Plus Vorinostat Maintenance in Women With Recurrent, Platinum-Sensitive Epithelial Ovarian, Fallopian Tube, or
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
2 Locations available
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Conditions: Kidney Cancer - Head and Neck Cancer - Breast Cancer - Non-small Cell Lung Cancer - Colorectal Cancer - Pancreatic Cancer - Ovarian Cancer - Esophageal Cancer - Gliomas
1 Location available
- Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer
Conditions: Ovarian Cancer
3 Locations available
- ABT-888 and Topotecan Hydrochloride in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Ovarian Epithelial Cancer or Primary Per
Conditions: Ovarian Cancer - Primary Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
3 Locations available
- Study of Individuals and Families at High Risk for Testicular Cancer
Conditions: Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Ovarian Cancer - Testicular Germ Cell Tumor
1 Location available
- Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors - Intraocular Melanoma - Lung Cancer - Melanoma (Skin) - Metastatic Cancer - Neuroblastoma - Ovarian Cancer - Retinoblastoma - Sarcoma - Small Intestine Cancer
1 Location available
- Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes
Conditions: Ovarian Cancer
1 Location available
- Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Hereditary Breast and Ovarian Cancer Syndrome - Unspecified Adult Solid Tumor, Protocol Specific
6 Locations available
- A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- The Effect of TRA-8 on Ovarian Cancer Tissue
Conditions: Ovarian Cancer
1 Location available
- Cancer Screening and Prevention Program for High Risk Women
Conditions: Ovarian Cancer - Breast Cancer
3 Locations available
- Assessment of Screening Modalities for Gynecologic Cancers
Conditions: Ovarian Cancer - Endometrial Cancer
1 Location available
- Laboratory Study in Predicting Tumor Response to Chemotherapy in Patients With Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
1 Location available
- Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer - Psychosocial Effects of Cancer and Its Treatment
126 Locations available
- Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Ovarian Epithelial Canc
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
17 Locations available
- Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Rec
Conditions: Cognitive/Functional Effects - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
164 Locations available
- Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
2 Locations available
- Cediranib and Olaparib in Combination for Recurrent Ovarian or Triple-Negative Breast Cancer
Conditions: Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
5 Locations available
- Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer
Conditions: Breast Cancer - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
119 Locations available
- Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Conditions: Ovarian Cancer
65 Locations available
- RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: Anal Cancer - Breast Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Lung Cancer - Nonneoplastic Condition - Ovarian Cancer - Unspecified Adult Solid Tumor, Protocol Specific
6 Locations available
- AFP464 in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Kidney Cancer - Ovarian Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
Conditions: Childhood Germ Cell Tumor - Ovarian Cancer - Teratoma
1 Location available
- Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors and Multiple Myeloma
Conditions: Ovarian Cancer - Renal Cancer - Non-small Cell Lung Cancer - Small Cell Lung Cancer - Solid Tumors - Multiple Myeloma
7 Locations available
- Intraperitoneal Paclitaxel, Doxorubicin, and Cisplatin in Treating Patients With Endometrial Cancer
Conditions: Endometrial Cancer - Ovarian Cancer
5 Locations available
- Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
Conditions: Breast Neoplasms - Ovarian Neoplasms - Colonic Neoplasms - Prostatic Neoplasms - Uterine Cervical Neoplasms - Leukemia - Lymphoma, Non-Hodgkin
1 Location available
- Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Conditions: Ovarian Cancer - Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblasto
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Liver Cancer - Neuroblastoma - Ototoxicity - Ovarian Cancer - Sarcoma
69 Locations available
- Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer - Uterine Cancer - Vaginal Cancer - Vulvar Cancer
1 Location available
- A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tum
Conditions: Solid Tumors - Ovarian Cancer
7 Locations available
- Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome
Conditions: Breast Cancer - Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Ovarian Cancer - Testicular Germ Cell Tumor
1 Location available
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Fallopian Tube Cancer - Ovarian Cancer
130 Locations available
- Paclitaxel With or Without Viral Therapy in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal C
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
5 Locations available
- Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
Conditions: Melanoma - Ovarian Cancer - Sarcoma - BONE - CNS-SPINAL CD/MEMBR,NOS - LYMPH NODES - SOFT TISSUE
1 Location available
- Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remis
Conditions: Fallopian Tubes - Ovarian Cancer - Peritoneal Cancer
1 Location available
- VTX-2337 and Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal C
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
6 Locations available
- Vaccine Therapy in Treating Patients With Stage III-IV Ovarian Cancer
Conditions: Stage III Ovarian Epithelial Cancer - Stage III Ovarian Germ Cell Tumor - Stage IV Ovarian Epithelial Cancer - Stage IV Ovarian Germ Cell Tumor
1 Location available
- Study of Individuals and Families at High Risk for Breast or Ovarian Cancer
Conditions: Breast Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer
1 Location available
- Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epitheli
Conditions: Ovarian Cancer - Primary Peritoneal Cavity Cancer
1 Location available
- Karenitecin Versus Topotecan in Patients With Advanced Epithelial Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- Ovarian Dendritic Cell Vaccine Trial
Conditions: Ovarian Cancer
1 Location available
- A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ova
Conditions: Cancer - Carcinoma - Fallopian Tube Cancer - Gynecological Malignancies - Metastases - Oncology - Ovarian Cancer - Solid Tumors - Tumors
8 Locations available
- Temsirolimus and Bevacizumab in Treating Patients With Locally Advanced, Recurrent, Metastatic, or Progressive Endometrial Cancer, Ovarian Epithelial
Conditions: Endometrial Cancer - Gastrointestinal Carcinoid Tumor - Islet Cell Tumor - Liver Cancer - Lung Cancer - Ovarian Cancer
6 Locations available
- A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck
Conditions: Ovarian Cancer - Non Small Cell Lung Cancer - Prostate Cancer - Colorectal Cancer - Gastric Cancer - Esophageal Cancer - Cancer of Head and Neck
23 Locations available
- MLN8237 in Patients With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breas
Conditions: Ovarian Carcinoma - Fallopian Tube Cancer - Peritoneal Cancer - Breast Carcinoma
2 Locations available
- Seprafilm™ for the Prevention of Intraperitoneal Adhesions and Improved Delivery of Therapy in Women Undergoing Staging and Intraperitoneal Chemothera
Conditions: Epithelial Ovarian Cancer
1 Location available
- Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer - Breast Cancer
1 Location available
- Autologous OC-DC Vaccine in Ovarian Cancer
Conditions: Chemotherapy - Tumor - Ovarian Cancer
1 Location available
- WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Carcinoma
1 Location available
- Safety Study of MGAH22 in HER2-positive Carcinomas
Conditions: Breast Cancer - Gastric Cancer - Bladder Cancer - Ovarian Cancer - Non-small Cell Lung Cancer
2 Locations available
- Phase II of Carbo/Pralatrexate in Rec. Platinum-Sensitive Ovarian, Fallopian or Primary Peritoneal Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
2 Locations available
- A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers
Conditions: Locally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer, - Primary Peritoneal Cancer or Endometrial Cancer - Locally Advanced/Metastatic Her2 Non Overexpressing Breast Cancer
3 Locations available
- Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer
Conditions: Healthy, no Evidence of Disease - Hereditary Breast/Ovarian Cancer - BRCA1 - Hereditary Breast/Ovarian Cancer - BRCA2
3 Locations available
- Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and Solids
Conditions: Endometrial Cancer - Ovarian Cancer
1 Location available
- Carboplatin, Pegylated Liposomal Doxorubicin Hydrochloride, and Everolimus in Treating Patients With Relapsed Ovarian Epithelial, Fallopian Tube, or P
Conditions: Fallopian Tube Cancer - Peritoneal Cavity Cancer - Recurrent Ovarian Epithelial Cancer
1 Location available
- Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors
Conditions: Advanced Solid Malignant Tumors - Advanced Ovarian Cancer
4 Locations available
- Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Conditions: Ovarian Cancer
35 Locations available
- Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer
Conditions: Ovarian Cancer
37 Locations available
- Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- AZD2281 and Carboplatin in Treating Patients With BRCA1/BRCA2-Associated, Hereditary, or Triple Negative Metastatic or Unresectable Breast Cancer or O
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer
1 Location available
- OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
29 Locations available
- ABT-888 in Treating Patients With Malignant Solid Tumors That Did Not Respond to Previous Therapy
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Breast Cancer - Fallopian Tube Cancer - Hereditary Breast/Ovarian Cancer (brca1, brca2) - Ovarian Cancer - Pancreatic Cancer - Peritoneal Cavity Cancer - Prostate Cancer - Unspecified Adult Solid Tumor, Pr
1 Location available
- Lysophosphatidic Acid Assay in Patients With Ovarian Cancer or Who Are at Risk for Ovarian Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Ovarian Cancer
1 Location available
- Pemetrexed and Carboplatin in Recurrent Platinum Sensitive Ovarian Cancer
Conditions: Ovarian Cancer - Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- M. D. Anderson Symptom Inventory - Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
30 Locations available
- Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Prim
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
7 Locations available
- A Phase 1 Study in Patients With Advanced Cancer
Conditions: Advanced Cancer - Non Small Cell Lung Cancer - Colorectal Cancer - Ovarian Cancer
2 Locations available
- Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, Peritoneal Cancer, or Recurrent T
Conditions: Breast Cancer - Fallopian Tube Cancer - Ovarian Cancer - Malignant Tumor of Peritoneum
22 Locations available
- Neoadjuvant Therapy for Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
4 Locations available
- SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cis
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Canc
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cancer
26 Locations available
- Olaparib in Combination With Carboplatin for Refractory or Recurrent Women's Cancers
Conditions: Mixed Muellerian Cancer - Cervical Cancer - Ovarian Cancer - Breast Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer - Endometrial Cancer - Carcinosarcoma
1 Location available
- DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Conditions: Pleuropulmonary Blastoma - Cystic Nephroma - Ovarian Sertoli-Leydig Cell Tumors - Ocular Medulloepithelioma - Nasal Chondromesenchymal Hamartoma
1 Location available
- Therapeutic Targeting of Stress Factors in Ovarian Cancer Patients
Conditions: Invasive Epithelial Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
1 Location available
- Analyzing the Composition of Tears to Identify Cancer
Conditions: Breast Cancer - Ovarian Cancer - Colon Cancer - Benign Disease
1 Location available
- ChemoFx® PRO - A Post-Market Data Collection Study
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer - Uterine Neoplasms - Endometrial Cancer - Vaginal Cancer - Vulvar Cancer - Cervical Cancer - Lung Cancer - Carcinoid Tumor of Lung - Sarcoma of Lung - Mesothelioma - Colorectal Cancer
59 Locations available
- Exhaled Breath Biomarkers in Finding Ovarian Epithelial Cancer in Patients With Newly Diagnosed Ovarian Epithelial Cancer, Polycystic Ovarian Syndrome
Conditions: Ovarian Cancer
4 Locations available
- Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer
Conditions: Tumor - Ovarian Cancer
11 Locations available
- Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity
Conditions: Ovarian Cancer - Peritoneal Cavity Cancer - Unspecified Adult Solid Tumor, Protocol Specific
1 Location available
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
98 Locations available
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
359 Locations available
- Alvocidib and Oxaliplatin With or Without Fluorouracil and Leucovorin Calcium in Treating Patients With Relapsed or Refractory Germ Cell Tumors
Conditions: Extragonadal Germ Cell Tumor - Ovarian Cancer - Testicular Germ Cell Tumor
9 Locations available
- A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Carcinoma
4 Locations available
- First-line Treatment of Weekly Paclitaxel With Carboplatin and Bevacizumab in Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Primary Peritoneal Cancer - Fallopian Tube Cancer
1 Location available
- EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
11 Locations available
- N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer
Conditions: Ovarian Carcinoma, Stage 3 or 4 - Epithelial Ovarian Carcinoma - Primary Peritoneal Carcinoma
1 Location available
- Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer
Conditions: Neoplasms - Ovarian Neoplasms - Fallopian Tube Neoplasms - Primary Peritoneal Neoplasm
5 Locations available
- MK-2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Trial of Adjuvant FANG™ Vaccine for High Risk Stage IIIc Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- A Study of MK-1775 in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone for Participants With Platinum-Sensitive Ova
Conditions: Ovarian Cancer
3 Locations available
- Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Patients With Non-Small Cell Lung Cancer and Platinum Resistant Ovarian Cancer
Conditions: Non-Small Cell Lung Cancer, Ovarian Cancer
3 Locations available
- A Study of MM-121 With Paclitaxel in Platinum Resistant/ Refractory Advanced Ovarian Cancers
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
10 Locations available
- Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplan
Conditions: Chronic Myeloproliferative Disorders - Kidney Cancer - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Neuroblastoma - Oral Complications - Ovarian Cancer - Pain
1 Location available
- Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Na
Conditions: Brain and Central Nervous System Tumors - Childhood Germ Cell Tumor - Extragonadal Germ Cell Tumor - Head and Neck Cancer - Lymphoma - Nausea and Vomiting - Neuroblastoma - Ovarian Cancer - Sarcoma
1 Location available
- Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Perito
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- Data Collection for Patients With Low Grade Ovarian Carcinoma
Conditions: Ovarian Cancer - Peritoneum Tumors
1 Location available
- Study of Adding AMG 479 to First Line Chemotherapy in Patients With Optimally Debulked Epithelial Ovarian Cancer
Conditions: Ovarian Neoplasms
14 Locations available
- Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian S
Conditions: Ovarian Cancer
47 Locations available
- Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Conditions: Pleural Metastases - Breast Cancer - Colon Cancer - Ovarian Cancer - Uterine Cancer - Renal Cell Cancer - Thymic Cancer
1 Location available
- A Phase I Study of MGAH22 in Patients With Refractory HER2 Positive Cancers
Conditions: Non-Small Cell Lung Neoplasms - Prostate Neoplasms - Bladder Neoplasms - Ovarian Neoplasms - Breast Neoplasms
1 Location available
- Predictors of Ovarian Insufficiency in Young Breast Cancer Patients
Conditions: Breast Cancer - Ovarian Insufficiency - Ovarian Failure
2 Locations available
- Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer
Conditions: Ovarian Cancer - Epithelial Ovarian Cancer - Fallopian Tube Carcinoma - Primary Peritoneal Carcinoma
1 Location available
- Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and P
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
1 Location available
- Panitumumab and Gemcitabine in Relapsed Ovarian Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel
Conditions: Ovarian Cancer Recurrent
7 Locations available
- Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Conditions: Recurrent Ovarian Cancer - Fallopian Tube Carcinoma - Primary Peritoneal Carcinoma
6 Locations available
- Ovarian Reserve Testing in Female Young Adult Cancer Survivors
Conditions: Cancer - Infertility
1 Location available
- Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Conditions: Breast Neoplasms - Ovarian Neoplasms
1 Location available
- AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
Conditions: Breast Cancer - Ovarian Cancer
1 Location available
- TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer
14 Locations available
- Investigating the Impact of Tamoxifen Therapy on Ovarian Aging
Conditions: Breast Cancer - Fertility
1 Location available
- TKM 080301 for Primary or Secondary Liver Cancer
Conditions: Colorectal Cancer With Hepatic Metastases - Pancreas Cancer With Hepatic Metastase - Gastric Cancer With Hepatic Metastase - Breast Cancer With Hepatic Metastase - Ovarian Cancer With Hepatic Metastase
1 Location available
- EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer
Conditions: Ovarian Cancer Recurrent
3 Locations available
- Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: brca1 Mutation Carrier - brca2 Mutation Carrier - Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
30 Locations available
- Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer
Conditions: Peritoneal Cancer
1 Location available
- Early Detection of Ovarian Cancer
Conditions: Ovarian Cancer
5 Locations available
- Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Canc
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cavity Cancer
1 Location available
- A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer
Conditions: Ovarian Cancer
4 Locations available
- Glycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female Participants
Conditions: Ovarian Cancer
1 Location available
- Thermal Spread Into the Interstitial Portion of the Fallopian Tubes Using the Ligasure Device at Time of Hysterectomy
Conditions: Cervical Cancer - Ovarian Cancer - Uterine Cancer
1 Location available
- Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
23 Locations available
- Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Conditions: Breast Cancer - Ovarian Cancer - Gynecologic Cancers - Ovarian/Peritoneal/Fallopian Cancer
1 Location available
- A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women
Conditions: Epithelial Ovarian Cancer
4 Locations available
- Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Conditions: Fallopian Tube Neoplasms - Ovarian Cancer - Primary Peritoneal
1 Location available
- Pemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid Tumors
Conditions: Breast Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Lung Cancer - Ovarian Cancer - Prostate Cancer
1 Location available
- Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab
Conditions: Fallopian Tubes Cancer - Ovarian Cancer - Peritoneal Cancer
1 Location available
- Narrow Band Imaging (NBI): A Novel Imaging Modality in Laparoscopic and Robotic Surgery
Conditions: Endometrial Cancer - Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer
1 Location available
- Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases - Ovarian Neoplasms
1 Location available
- Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian Cancer
Conditions: Ovarian Carcinoma - Fallopian Tube Cancer - Primary Peritoneal Cancer
1 Location available
- Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
Conditions: Malignant Solid Tumour - Breast Cancer - Malignant Tumor of Colon - GIST - Ovarian Cancer
1 Location available
- Effects of Controlled Ovarian Hyperstimulation (COH) With Letrozole and Gonadotropin
Conditions: Infertility - Breast Cancer
1 Location available
- Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand
Conditions: Ovarian Cancer
1 Location available
- Fallopian Tube Removal as a Method of Ovarian Cancer Prevention: A Descriptive Study
Conditions: Ovarian Cancer
1 Location available
- Autologous T Cells Expressing Enhanced TCRs Specific for MAGEA3/A6/B18 or NYESO-1/LAGE in Patients With Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- A Evaluation of Metformin, Targeting Cancer Stem Cells for the Prevention of Relapse in Patients With Stage IIC/III/IV Ovarian, Fallopian Tube, and Pr
Conditions: Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
1 Location available
- Phase Ib Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Conditions: Ovarian Cancer - Endometrial Cancer
2 Locations available
- Risk Education and Assessment for Cancer Heredity
Conditions: Breast Cancer - Ovarian Cancer - Genetic Predisposition
1 Location available
- Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavit
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
101 Locations available
- Pilot Program to Personalize Care & Improve Quality of Life for Women With Recurrent Ovarian Cancer
Conditions: Ovarian Cancer
1 Location available
- Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer
Conditions: Ovarian Cancer - Peritoneal Cancer - Fallopian Tube Cancer
3 Locations available
- Beta-Blocker / Ovarian
Conditions: Ovarian Cancer - Primary Peritoneal Carcinoma - Fallopian Tube Cancer
1 Location available
- Salvage Ovarian FANG Vaccine + Bevacizumab
Conditions: Stage IIIC Ovarian Cancer
1 Location available
- Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies
Conditions: Solid Tumor - Breast Cancer - Ovarian Cancer - Pancreatic Cancer - Non-Small Cell Lung
2 Locations available
- Collection of Tissue Samples From Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Conditions: Ovarian Cancer
1 Location available
- Veliparib, Cisplatin, and Vinorelbine Ditartrate in Treating Patients With Recurrent and/or Metastatic Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer - Hereditary Breast/Ovarian Cancer - BRCA1 - Hereditary Breast/Ovarian Cancer - BRCA2 - Male Breast Cancer - Progesterone Receptor-negative Breast Cancer - Recurrent Breast Cancer - Stage IIIC Breast Cancer - Stage
1 Location available
- GDC-0449 and RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma
Conditions: Adult Malignant Fibrous Histiocytoma of Bone - Gastrointestinal Stromal Tumor - Kidney Cancer - Malignant Neoplasm of Conjunctiva - Ovarian Cancer - Sarcoma - Small Intestine Cancer
1 Location available
- Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer)
Conditions: Breast Cancer - Ovarian Cancer
1 Location available
- Changes in Performance Status and Symptom Distress in Older Patients With Advanced Ovarian Epithelial Cancer Undergoing Surgery and/or Chemotherapy
Conditions: Ovarian Cancer
1 Location available
- Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Clear Cell Ovarian Can
Conditions: Ovarian Cancer
72 Locations available
- Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies
Conditions: Malignancy - Cancer - Non Small Cell Lung Cancer - Small Cell Lung Cancer - Testicular Cancer - Thymoma - Ovarian Cancer - Osteosarcoma
4 Locations available
- The Effect of Guided Imagery and Music Therapy on Post-Operative Recovery After Gynecological Oncology Surgery
Conditions: Ovarian Cancer - Uterine Cancer
1 Location available
- Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
8 Locations available
- Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavi
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
72 Locations available
- Safety Study of MGA271 in Refractory Cancer
Conditions: Prostate Cancer - Pancreatic Cancer - Melanoma - Renal Cell Carcinoma - Ovarian Cancer - Colorectal Cancer - Gastric Cancer - Bladder Cancer - Non-small Cell Lung Cancer - Glioblastoma
3 Locations available
- Phase 1-2 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
Conditions: Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer
2 Locations available
- Veliparib, Pegylated Liposomal Doxorubicin Hydrochloride, and Carboplatin in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cance
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
4 Locations available
- Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Persistent or Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
79 Locations available
- A Study of DMOT4039A in Patients With Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
Conditions: Ovarian Cancer, Pancreatic Cancer
2 Locations available
- Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy
Conditions: Epithelial Ovarian Cancer
2 Locations available
- Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Peritoneal Cancer
1 Location available
- Safety and Pharmacokinetics of DMUC5754A Administered Intravenously to Patients With Platinum-Resistant Ovarian Cancer
Conditions: Ovarian Cancer
3 Locations available
- Pelvic Floor Disorders in Survivors of Gynecologic Malignancies
Conditions: Uterine Cancer - Ovarian Cancer - Fallopian Tube Cancer - Peritoneal Cancer - Cervical Cancer - Vulvar Cancer
1 Location available
- Amatuximab for High Mesothelin Cancers
Conditions: Carcinoma, Pancreatic Ductal - Mesothelioma - Ovarian Neoplasms - Carcinoma, Non-Small-Cell Lung
1 Location available
- Phase I Stereotactic Body Radiation for Metastatic or Recurrent Platinum-Resistant Ovarian Cancer
Conditions: Recurrent Ovarian Epithelial Cancer - Recurrent Ovarian Germ Cell Tumor - Malignant Tumor of Peritoneum - Stage IV Ovarian Epithelial Cancer - Stage IV Ovarian Germ Cell Tumor
1 Location available
- A Single-Dose Pilot Study of Radiolabeled Amatuximab (MORAb-009) in Mesothelin Over Expressing Cancers
Conditions: Mesothelioma - Pancreatic Cancer - Ovarian Cancer - Non-small Cell Lung Cancer
1 Location available
- Cryopreservation of Ovarian Tissue
Conditions: Cancer - Risk of Premature Ovarian Failure - Fertility Preservation
1 Location available
- Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
Conditions: Anxiety Disorder - Fallopian Tube Cancer - Fatigue - Nausea and Vomiting - Neurotoxicity - Ovarian Cancer - Primary Peritoneal Cavity Cancer
88 Locations available
- Acute Normovolemic Hemodilution in Patients Undergoing Cytoreductive Surgery for Advanced Ovarian Cancer
Conditions: Epithelial Ovarian Cancer - Fallopian Tube Cancer - Primary Peritoneal Carcinoma
1 Location available
- A Study of Oral Rucaparib in Patients With gBRCA Mutation Breast or Ovarian Cancer, or Other Solid Tumor
Conditions: Metastatic Solid Tumor - Breast Cancer - Ovarian Cancer
2 Locations available
- Surgical Trial Comparing LIGASURE Assisted Recto-Sigmoid Resection and Omentectomy Compared to Stand
Conditions: Epithelial Ovarian Cancer
2 Locations available
|